Purohit OP - Search Results

1

High-dose intravenous pamidronate for metastatic bone pain.

Purohit OP, Anthony C, Radstone CR, Owen J, Coleman RE. Purohit OP, et al. Br J Cancer. 1994 Sep;70(3):554-8. doi: 10.1038/bjc.1994.344. Br J Cancer. 1994. PMID: 8080746 Free PMC article. Clinical Trial.

2

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.

Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE. Purohit OP, et al. Br J Cancer. 1995 Nov;72(5):1289-93. doi: 10.1038/bjc.1995.502. Br J Cancer. 1995. PMID: 7577484 Free PMC article. Clinical Trial.

3

Osteoclast inhibition for the treatment of bone metastases.

Coleman RE, Purohit OP. Coleman RE, et al. Among authors: purohit op. Cancer Treat Rev. 1993 Jan;19(1):79-103. doi: 10.1016/0305-7372(93)90028-p. Cancer Treat Rev. 1993. PMID: 8431928 Review. No abstract available.

4

Metabolic effects of pamidronate in patients with metastatic bone disease.

Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE. Vinholes J, et al. Among authors: purohit op. Br J Cancer. 1996 May;73(9):1089-95. doi: 10.1038/bjc.1996.210. Br J Cancer. 1996. PMID: 8624269 Free PMC article. Clinical Trial.

5

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.

Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE. Vinholes J, et al. Among authors: purohit op. J Clin Oncol. 1997 Jan;15(1):131-8. doi: 10.1200/JCO.1997.15.1.131. J Clin Oncol. 1997. PMID: 8996134 Clinical Trial.

6

High dose pamidronate: clinical and biochemical effects in metastatic bone disease.

Coleman RE, Purohit OP, Vinholes JJ, Zekri J. Coleman RE, et al. Among authors: purohit op. Cancer. 1997 Oct 15;80(8 Suppl):1686-90. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1686::aid-cncr20>3.3.co;2-t. Cancer. 1997. PMID: 9362437 Clinical Trial.

7

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease.

Vinholes JJ, Purohit OP, Abbey ME, Eastell R, Coleman RE. Vinholes JJ, et al. Among authors: purohit op. Ann Oncol. 1997 Dec;8(12):1243-50. doi: 10.1023/a:1008238422151. Ann Oncol. 1997. PMID: 9496390 Free article. Clinical Trial.

8

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer.

Coleman RE, Houston S, Purohit OP, Rubens RD, Kandra A, Ford J. Coleman RE, et al. Among authors: purohit op. Eur J Cancer. 1998 May;34(6):820-4. doi: 10.1016/s0959-8049(97)10155-1. Eur J Cancer. 1998. PMID: 9797692 Clinical Trial.

9

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease.

Coleman RE, Purohit OP, Black C, Vinholes JJ, Schlosser K, Huss H, Quinn KJ, Kanis J. Coleman RE, et al. Among authors: purohit op. Ann Oncol. 1999 Mar;10(3):311-6. doi: 10.1023/a:1008386501738. Ann Oncol. 1999. PMID: 10355575 Free article. Clinical Trial.

10

Bone resorption predicts for skeletal complications in metastatic bone disease.

Brown JE, Thomson CS, Ellis SP, Gutcher SA, Purohit OP, Coleman RE. Brown JE, et al. Among authors: purohit op. Br J Cancer. 2003 Dec 1;89(11):2031-7. doi: 10.1038/sj.bjc.6601437. Br J Cancer. 2003. PMID: 14647134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters